Skip to Main Content

Paper Details

Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness.
J Infect Dis
4
2023
Alpha, COVID, COVID-19, Delta variant, SARS, SARS-CoV-2, WGS, people
COVID-19, COVID-19 Vaccines, Case-Control Studies, Hepatitis D, Humans, Immune Evasion, SARS-CoV-2, Vaccine Efficacy
Author NameAffiliation
Margaret L LindYale School of Public Health
Richard CopinRegeneron Pharmaceuticals
Shane McCarthyRegeneron Pharmaceuticals
Shane McCarthyRegeneron Pharmaceuticals
Andreas CoppiYale School of Medicine
Andreas CoppiCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Fred WarnerYale School of Medicine
Fred WarnerCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
David FergusonCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Chelsea DuckwallYale School of Public Health
Ryan BorgYale School of Public Health
M Catherine MuenkerYale School of Public Health
John D OvertonRegeneron Pharmaceuticals
John D OvertonRegeneron Pharmaceuticals
Sara C HamonRegeneron Pharmaceuticals
Anbo ZhouRegeneron Pharmaceuticals
Derek A T CummingsUniversity of Florida
Derek A T CummingsEmerging Pathogens Institute, University of Florida
Albert I KoYale School of Public Health
Albert I KoInstituto Goncalo Moniz
Jennifer D HamiltonRegeneron Pharmaceuticals
Wade Schulz (CM4AI)Yale School of Medicine
Wade Schulz (CM4AI)Yale University School of Medicine
  • 1 - 23

Datasets

Release 1.2